4//SEC Filing
Dasu Badri N 4
Accession 0001209191-22-016248
CIK 0001427925other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 4:25 PM ET
Size
5.2 KB
Accession
0001209191-22-016248
Insider Transaction Report
Form 4
Dasu Badri N
Chief Engineering Officer
Transactions
- Tax Payment
Common Stock
2022-03-03$0.41/sh−5,612$2,283→ 300,595 total
Footnotes (3)
- [F1]Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs.
- [F2]Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
- [F3]Balance includes non-reportable acquisition of 10,000 shares of Common Stock through the Company's Employee Stock Purchase Plan.
Documents
Issuer
ACELRX PHARMACEUTICALS INC
CIK 0001427925
Entity typeother
Related Parties
1- filerCIK 0001310803
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 4:25 PM ET
- Size
- 5.2 KB